Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Invivo Therapeutics Holdings (NVIVQ)
OTHER OTC:NVIVQ
Holding NVIVQ?
Track your performance easily
NVIVQ Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.15 - $1.41
Previous Close$0.34
Volume1.34K
Average Volume (3M)8.47K
Market Cap
$1.06M
Enterprise Value-$7.53M
Total Cash (Recent Filing)$8.58M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.29
Next Earnings
Apr 01, 2019EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.32
Shares Outstanding3,105,446
10 Day Avg. Volume18,077
30 Day Avg. Volume8,470
Standard Deviation0.27
R-Squared0.00242
Alpha-0.08
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.13
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.82
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NVIVQ FAQ
What was Invivo Therapeutics Holdings’s price range in the past 12 months?
Invivo Therapeutics Holdings lowest stock price was $0.15 and its highest was $1.41 in the past 12 months.
What is Invivo Therapeutics Holdings’s market cap?
Currently, no data Available
When is Invivo Therapeutics Holdings’s upcoming earnings report date?
Invivo Therapeutics Holdings’s upcoming earnings report date is Apr 01, 2019 which is 2097 days ago.
How were Invivo Therapeutics Holdings’s earnings last quarter?
Invivo Therapeutics Holdings released its earnings results on Nov 08, 2018. The company reported -$315 earnings per share for the quarter, missing the consensus estimate of N/A by -$315.
Is Invivo Therapeutics Holdings overvalued?
According to Wall Street analysts Invivo Therapeutics Holdings’s price is currently Overvalued.
Does Invivo Therapeutics Holdings pay dividends?
Invivo Therapeutics Holdings does not currently pay dividends.
What is Invivo Therapeutics Holdings’s EPS estimate?
Invivo Therapeutics Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Invivo Therapeutics Holdings have?
Invivo Therapeutics Holdings has 3,105,446 shares outstanding.
What happened to Invivo Therapeutics Holdings’s price movement after its last earnings report?
Invivo Therapeutics Holdings reported an EPS of -$315 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Invivo Therapeutics Holdings?
Currently, no hedge funds are holding shares in NVIVQ
---
Company Description
Invivo Therapeutics Holdings
Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. The company was founded by Joseph P. Vacanti, Frank M. Reynolds, and Robert Langer in January 2005 and is headquartered in Cambridge, MA.
---
Technical Analysis
---